ovarian cancer biomarker News
Most Popular ovarian cancer biomarker Story
DNA biomarkers may improve ovarian cancer outcomes
Ovarian cancer is a silent killer--most women present late, and only have a 30% survival rate over 5 years. However, if it is diagnosed early, 90% of these women could survive, and a panel of Read more...
Latest Headlines
Molecular profiling informs ovarian cancer rescue treatment
As the fifth leading cause of cancer-related death in women in the U.S., ovarian cancer is a tough diagnosis to deal with, especially if the cancer comes back. Biomarkers can be used to point to the Read more...
DNA biomarkers may improve ovarian cancer outcomes
Ovarian cancer is a silent killer--most women present late, and only have a 30% survival rate over 5 years. However, if it is diagnosed early, 90% of these women could survive, and a panel of Read more...
MicroRNA marks ovarian cancer outcome
Ovarian cancer can be hard to treat--because the disease can have non-specific symptoms, patients often only come forward when the cancer is quite advanced. Additionally, some women develop Read more...
Screening method could help prevent multiple types of cancer
A new genetic screening method called BROCA located mutations in 12 genes for inherited cancers of the ovary, fallopian tubes and peritoneum. The study, led by Dr. Elizabeth Swisher at the University Read more...
FDA approves test to determine chances of ovarian cancer
The FDA has given 510(k) clearance to Fujirebio Diagnostics to market the company's test to detect whether the silent killer of ovarian cancer is stalking women who come into physicians' offices with Read more...
Scientists may have found early biomarker for ovarian cancer
An antibody present in infertile women might also be an early biomarker for ovarian cancer, raising hopes that more lives can be saved with early detection of what is often called a "silent killer," Read more...
HealthLinx shares spike on ovarian cancer test data
Shares of Australia's HealthLinx shot up after the biotech announced that its diagnostic test for ovarian cancer outperformed the diagnostic tool now in use. Investigators said that OvPlex Read more...
